Global Plasma-derived Therapies Market Size, Status and Forecast 2022-2028

Plasma-derived therapeutics start from human blood plasma instead of the chemical or synthetic materials from which most pharmaceuticals are made.
According to our latest research, the global Plasma-derived Therapies market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
Global Plasma-derived Therapies Scope and Market Size
This report focuses on the global Plasma-derived Therapies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Plasma-derived Therapies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
Segment by Type
Albumin
Immunoglobulin
Factor VIII
Others
Segment by Application
Hemophilia
Primary Immunodeficiencies (PIDs)
Idiopathic Thrombocytopenic Purpura (ITP)
COVID-19
Others
By Region
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
By Company
CSL Behring LLC
Shire
Bayer
Kedrion
Takeda
Biotest
Octaparma
Bio Products Laboratory (BPL)
LFB
Grifols

Frequently Asked Questions